Clinical trial compensation varies dramatically — from $25 per visit for routine outpatient studies to $7,000+ for multi-week inpatient Phase 1 trials. The amount depends on the phase, the time commitment, the procedures involved, and the perceived risk. Understanding typical clinical trial compensation ranges helps potential participants evaluate offers fairly and make informed decisions about whether the time commitment is worth the payment. This guide breaks down compensation by phase, explains why amounts vary, covers tax treatment, and offers guidance on evaluating specific trial offers.
Why participants are compensated
Compensation in clinical trials is intended to cover the participant’s time, effort, and travel costs — not to incentivize participation in ways that could pressure people into joining trials they wouldn’t otherwise choose. The Office for Human Research Protections and most IRBs (Institutional Review Boards) carefully review compensation amounts to ensure they’re reasonable but not coercive.
This means trial compensation is generally moderate. Healthy volunteer Phase 1 studies pay more because they involve substantial time commitment (often inpatient stays), more procedures, and somewhat higher uncertainty. Patient-focused trials in Phase 2-3 pay less because the participant is also receiving potential treatment benefit and the visits are integrated into normal life.
Compensation by phase
Phase 1 healthy volunteer studies:
- Outpatient single-visit studies: $50-300
- Multi-visit outpatient studies: $500-2,000
- Short inpatient stays (1-3 nights): $1,000-3,000
- Extended inpatient stays (1-4 weeks): $3,000-7,000+
Phase 1 oncology trials (patients with advanced disease):
- Typically minimal direct compensation — drug, procedures, and study visits are covered
- Travel and lodging often provided
- Standard care is usually billed to insurance separately
Phase 2 and 3 trials (patients with target condition):
- Per-visit compensation: $25-100 typical
- Some trials offer milestone payments at specific timepoints
- Travel reimbursement common for distant participants
- Total over a year-long trial: typically $300-1,500
Phase 4 post-marketing studies typically don’t compensate participants because the drug is already approved and used as standard care.
What affects compensation amounts
Several factors determine the compensation level for a specific trial:
Time commitment: The number of visits, length of each visit, and duration of follow-up. Trials requiring weekly visits over years compensate more total than trials requiring monthly visits over six months.
Inpatient vs outpatient: Inpatient stays involve giving up substantial time and require higher compensation. Outpatient visits with minimal duration are compensated less.
Procedures involved: Trials requiring blood draws, biopsies, imaging, or other procedures pay more than those requiring only questionnaires and physical exams. Invasive or uncomfortable procedures command higher compensation.
Risk level: Phase 1 trials of novel drugs with limited human exposure have higher compensation than Phase 3 trials of drugs with established safety profiles.
Geographic factors: Trials in high-cost-of-living areas often compensate more than trials in lower-cost areas, partly to attract participants and partly to reflect cost of living.
Travel and ancillary expenses
Beyond direct compensation, many trials cover or reimburse:
- Travel costs (mileage, gas, public transit, sometimes flights)
- Parking at the study site
- Lodging for participants traveling from outside the area
- Meals during long study visits or inpatient stays
- Childcare in some Phase 1 studies (less common in Phase 2-3)
These reimbursements typically don’t count as compensation — they’re recovery of expenses you wouldn’t have incurred without the trial. Tax treatment of reimbursements differs from compensation (covered below).
Tax treatment of clinical trial payments
Compensation from clinical trials is generally taxable income reported on a 1099-MISC if the total exceeds $600 in a calendar year from a single sponsor. Participants are responsible for reporting and paying taxes on this income.
Reimbursements for actual expenses (mileage, parking, lodging) are typically not taxable income because they’re recovery of costs. The IRS treats them as nontaxable as long as they’re properly documented and don’t exceed the actual expense.
For participants in multiple trials or making substantial income from trials, consult a tax professional. The IRS doesn’t have specific guidance on clinical trial compensation, but it’s treated as miscellaneous income for tax purposes.
How compensation is paid
Common payment methods include:
- Check mailed after each visit or at study completion
- Direct deposit (increasingly common)
- Prepaid debit cards (some trials)
- PayPal or similar (occasional)
Payment timing varies. Some trials pay after each visit; others pay at milestones (end of dosing, end of study). Phase 1 inpatient studies often pay a portion at admission and the balance at discharge. Confirm payment timing during the consent process.
What’s NOT included in compensation
Things that aren’t covered by trial compensation:
- Lost wages from missed work (some trials offer modest wage replacement, most don’t)
- Medical care for non-trial-related conditions (continues through normal insurance)
- Standard care for the target condition (usually billed to insurance separately)
- Medical expenses for adverse events (sponsor typically covers trial-related complications, but specifics vary)
The informed consent process should clearly explain what’s covered and what’s not. Read the consent forms carefully and ask about anything unclear.
Evaluating a specific trial’s compensation
Questions to ask when evaluating compensation:
- What’s the total compensation across the entire trial?
- Is it paid per visit or at milestones?
- What’s the time commitment per visit and total?
- Does the compensation include travel reimbursement or is travel separate?
- What’s the hourly equivalent if I divide compensation by total time commitment?
- Is there a milestone payment for completing the study?
- What’s the policy if I withdraw early — pro-rated payment or forfeiture?
For Phase 1 inpatient studies, doing the math on hourly rate is useful. A $3,000 payment for a study requiring 5 days inpatient (120 hours) plus 6 follow-up visits (12 hours) totals 132 hours, or roughly $23/hour — competitive with many part-time jobs.
Compensation for healthy volunteers vs patients
Healthy volunteer compensation (typically Phase 1) is higher because participants aren’t gaining therapeutic benefit. They’re contributing time, effort, and accepting some risk for compensation.
Patient compensation (typically Phase 2-3) is lower because participants may benefit from access to potentially effective treatments and intensive monitoring of their condition. The compensation primarily covers time and travel rather than payment for participation.
This distinction matters ethically. The IRB framework considers therapeutic benefit when reviewing compensation amounts, with the goal of ensuring participants aren’t coerced into joining trials by financial need.
Frequently Asked Questions
What’s the highest-paying clinical trial type?
Phase 1 healthy volunteer studies with extended inpatient stays. These can pay $5,000-10,000+ for several weeks of inpatient time and follow-up.
Are clinical trial payments taxable?
Yes, generally. Compensation over $600 from a single sponsor in a calendar year is reported on a 1099-MISC. Reimbursement for actual expenses (mileage, parking) is typically not taxable.
Do I get paid if I withdraw from a trial early?
Usually you receive pro-rated compensation for visits completed. Some trials have milestone payments that are forfeited if you don’t complete specific timepoints. Check the consent form for specifics.
Do all clinical trials pay participants?
No. Phase 4 post-marketing studies typically don’t compensate. Some Phase 1 oncology trials offer minimal direct compensation but cover travel and treatment. Many academic and observational studies don’t pay.
How much do COVID vaccine trial participants get paid?
Phase 3 COVID vaccine trials in 2020-2021 typically paid $25-100 per visit, with total compensation around $1,000-2,000 across the year-long study. Larger Phase 1 vaccine studies paid more for the time commitment.
The bottom line on clinical trial compensation
Clinical trial compensation varies from $25 per visit for outpatient Phase 2-3 studies to $7,000+ for multi-week Phase 1 inpatient studies. The amount reflects time commitment, procedures, risk, and therapeutic benefit considerations. Compensation is taxable income; expense reimbursement typically isn’t. Evaluate offers based on hourly equivalents and total time commitment, not just headline numbers. For most patients participating in trials related to their own medical conditions, the access to potentially beneficial treatments and intensive monitoring is a larger factor than the modest per-visit compensation.